Share Price and Basic Stock Data
Last Updated: January 24, 2026, 4:47 pm
| PEG Ratio | -3.81 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sudarshan Chemical Industries Ltd operates in the Dyes & Pigments sector and has reported significant revenue growth, with total sales rising from ₹2,201 Cr in FY 2022 to ₹2,302 Cr in FY 2023. The trailing twelve months (TTM) sales stood at ₹6,910 Cr, indicating robust performance. Quarterly sales data for FY 2025 shows a marked increase, with sales reaching ₹1,349 Cr in March 2025 and ₹2,507 Cr in June 2025. This growth trajectory highlights the company’s ability to capitalize on market demand, especially in a sector that typically experiences fluctuations due to raw material prices and global supply chain issues. The operational performance has been consistent, as evidenced by the operating profit margin (OPM) which stood at 11% for FY 2023, although it faced pressures in subsequent quarters, reflecting ongoing cost challenges. Overall, Sudarshan Chemical Industries demonstrates a strong capacity for revenue generation amidst a competitive landscape.
Profitability and Efficiency Metrics
Profitability metrics for Sudarshan Chemical reveal a mixed performance. The net profit reported for FY 2023 was ₹45 Cr, which reflected a decline from ₹130 Cr in FY 2022. The operating profit for the same period was ₹213 Cr, with an OPM of 9%, indicating challenges in maintaining profitability amidst rising costs. However, the interest coverage ratio (ICR) stood at a healthy 8.58x, suggesting that the company comfortably meets its interest obligations. The return on equity (ROE) was a modest 3.07%, and the return on capital employed (ROCE) was 6.03%, both of which are low compared to industry benchmarks. Efficiency metrics such as cash conversion cycle (CCC) stood at 353 days, indicating a potential area for improvement in working capital management. The company must focus on enhancing operational efficiency to improve profitability ratios moving forward.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sudarshan Chemical Industries displays a mix of strengths and weaknesses. As of FY 2025, total borrowings rose significantly to ₹2,528 Cr, a notable increase from ₹829 Cr in FY 2023. This rise in debt has implications for financial leverage, with a total debt to equity ratio of 0.60x, which while manageable, indicates increased financial risk. Reserves have increased to ₹3,504 Cr, reflecting a solid capital base for future investments. The price-to-book value (P/BV) ratio stood at 2.26x, suggesting that the market values the company higher than its book value, indicating investor confidence. However, with a current ratio of 2.12, the company maintains a comfortable liquidity position, enabling it to cover short-term liabilities. Overall, while the balance sheet reflects growth in reserves, the rising debt levels necessitate careful management to mitigate risks associated with higher leverage.
Shareholding Pattern and Investor Confidence
The shareholding structure of Sudarshan Chemical Industries provides insight into investor confidence. As of September 2025, promoters held 8.20% of the company, a significant decline from 35.82% in December 2022, indicating reduced confidence or strategic divestment by management. In contrast, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have increased their stakes to 8.54% and 24.17%, respectively, suggesting growing institutional interest. The public shareholding has risen to 59.08%, reflecting increased retail participation. The total number of shareholders stood at 63,691, indicating a diverse ownership base. This shift in the shareholding pattern, particularly the reduction in promoter stake, may raise concerns among investors regarding long-term strategic direction, while the growing institutional presence can be viewed positively, as it often correlates with a focus on governance and operational efficiency.
Outlook, Risks, and Final Insight
Looking ahead, Sudarshan Chemical Industries faces both opportunities and risks. The company’s robust revenue growth trajectory is encouraging, yet profitability remains a concern due to rising costs and operational inefficiencies. The significant increase in debt poses a financial risk that could impact future growth prospects if not managed effectively. Additionally, the declining promoter stake could weigh on investor sentiment, although the growing institutional interest may provide some support. The company’s ability to enhance operational efficiency and manage its debt levels will be critical. In scenarios where Sudarshan can successfully streamline operations and improve margins, it may stabilize its profitability and enhance shareholder value. Conversely, continued cost pressures and ineffective debt management could hinder growth and impact the company’s financial health. Overall, Sudarshan Chemical Industries must navigate these challenges strategically to capitalize on its market position and drive sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 32.9 Cr. | 108 | 190/68.5 | 18.1 | 162 | 0.92 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 33.6 Cr. | 56.0 | 226/56.0 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 611 Cr. | 494 | 1,148/472 | 22.4 | 91.7 | 0.20 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,588 Cr. | 318 | 570/272 | 33.0 | 62.2 | 1.57 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 58.4 Cr. | 52.0 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,186.23 Cr | 263.82 | 89.71 | 186.93 | 0.43% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 528 | 528 | 691 | 608 | 601 | 566 | 764 | 634 | 696 | 666 | 1,349 | 2,507 | 2,387 |
| Expenses | 486 | 486 | 606 | 538 | 535 | 504 | 645 | 553 | 602 | 587 | 1,222 | 2,314 | 2,255 |
| Operating Profit | 43 | 42 | 85 | 70 | 66 | 62 | 119 | 81 | 94 | 79 | 127 | 192 | 132 |
| OPM % | 8% | 8% | 12% | 11% | 11% | 11% | 16% | 13% | 14% | 12% | 9% | 8% | 6% |
| Other Income | 1 | 1 | 2 | 319 | 6 | 4 | 3 | 4 | -6 | -26 | -38 | 33 | 38 |
| Interest | 9 | 11 | 15 | 10 | 10 | 9 | 8 | 7 | 9 | 11 | 21 | 44 | 44 |
| Depreciation | 27 | 31 | 31 | 35 | 35 | 35 | 36 | 36 | 37 | 37 | 57 | 99 | 97 |
| Profit before tax | 8 | 1 | 41 | 344 | 26 | 22 | 78 | 41 | 43 | 5 | 11 | 82 | 30 |
| Tax % | 43% | 17% | 20% | 22% | 32% | 34% | 26% | 28% | 30% | 89% | 97% | 33% | 35% |
| Net Profit | 5 | 1 | 33 | 267 | 18 | 15 | 58 | 29 | 30 | 1 | 0 | 55 | 19 |
| EPS in Rs | 0.66 | 0.08 | 4.70 | 38.56 | 2.58 | 2.11 | 8.38 | 4.25 | 4.32 | 0.07 | -0.52 | 6.01 | 1.49 |
Last Updated: December 29, 2025, 12:40 am
Below is a detailed analysis of the quarterly data for Sudarshan Chemical Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2,387.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,507.00 Cr. (Jun 2025) to 2,387.00 Cr., marking a decrease of 120.00 Cr..
- For Expenses, as of Sep 2025, the value is 2,255.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,314.00 Cr. (Jun 2025) to 2,255.00 Cr., marking a decrease of 59.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 132.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Jun 2025) to 132.00 Cr., marking a decrease of 60.00 Cr..
- For OPM %, as of Sep 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Jun 2025) to 6.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Jun 2025) to 38.00 Cr., marking an increase of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 44.00 Cr..
- For Depreciation, as of Sep 2025, the value is 97.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 99.00 Cr. (Jun 2025) to 97.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Jun 2025) to 30.00 Cr., marking a decrease of 52.00 Cr..
- For Tax %, as of Sep 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 33.00% (Jun 2025) to 35.00%, marking an increase of 2.00%.
- For Net Profit, as of Sep 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Jun 2025) to 19.00 Cr., marking a decrease of 36.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.49. The value appears to be declining and may need further review. It has decreased from 6.01 (Jun 2025) to 1.49, marking a decrease of 4.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,106 | 1,205 | 1,401 | 1,282 | 1,329 | 1,593 | 1,708 | 1,864 | 2,201 | 2,302 | 2,539 | 3,346 | 6,910 |
| Expenses | 974 | 1,075 | 1,232 | 1,093 | 1,139 | 1,386 | 1,460 | 1,574 | 1,923 | 2,088 | 2,220 | 2,962 | 6,380 |
| Operating Profit | 133 | 131 | 170 | 189 | 191 | 207 | 248 | 290 | 278 | 213 | 318 | 383 | 531 |
| OPM % | 12% | 11% | 12% | 15% | 14% | 13% | 15% | 16% | 13% | 9% | 13% | 11% | 8% |
| Other Income | 2 | 23 | 14 | 25 | 15 | 81 | 22 | 7 | 5 | 5 | 332 | -67 | 6 |
| Interest | 43 | 41 | 37 | 30 | 25 | 19 | 16 | 20 | 23 | 44 | 39 | 51 | 120 |
| Depreciation | 37 | 42 | 48 | 49 | 58 | 66 | 74 | 87 | 89 | 114 | 141 | 166 | 290 |
| Profit before tax | 55 | 72 | 99 | 136 | 123 | 203 | 180 | 190 | 171 | 60 | 471 | 99 | 127 |
| Tax % | 37% | 24% | 29% | 25% | 31% | 33% | 20% | 26% | 24% | 25% | 24% | 39% | |
| Net Profit | 35 | 54 | 70 | 101 | 85 | 135 | 145 | 141 | 130 | 45 | 357 | 60 | 75 |
| EPS in Rs | 5.08 | 7.86 | 10.10 | 14.64 | 12.24 | 19.52 | 20.88 | 20.38 | 18.77 | 6.47 | 51.63 | 7.10 | 7.05 |
| Dividend Payout % | 30% | 22% | 30% | 24% | 29% | 31% | 30% | 29% | 27% | 23% | 9% | 63% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 54.29% | 29.63% | 44.29% | -15.84% | 58.82% | 7.41% | -2.76% | -7.80% | -65.38% | 693.33% | -83.19% |
| Change in YoY Net Profit Growth (%) | 0.00% | -24.66% | 14.66% | -60.13% | 74.67% | -51.42% | -10.17% | -5.04% | -57.58% | 758.72% | -776.53% |
Sudarshan Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -11% |
| 3 Years: | -18% |
| TTM: | -35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 46% |
| 1 Year: | 36% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:02 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 16 | 16 |
| Reserves | 264 | 249 | 300 | 367 | 426 | 554 | 587 | 730 | 819 | 814 | 1,135 | 3,424 | 3,504 |
| Borrowings | 440 | 433 | 430 | 433 | 431 | 367 | 501 | 618 | 823 | 829 | 467 | 2,378 | 2,528 |
| Other Liabilities | 217 | 317 | 346 | 379 | 433 | 424 | 522 | 638 | 705 | 725 | 730 | 3,854 | 3,706 |
| Total Liabilities | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 | 9,754 |
| Fixed Assets | 327 | 333 | 358 | 452 | 475 | 465 | 627 | 615 | 832 | 1,126 | 1,102 | 2,958 | 3,057 |
| CWIP | 7 | 8 | 15 | 8 | 6 | 24 | 48 | 278 | 285 | 44 | 15 | 140 | 159 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 548 | 539 |
| Other Assets | 594 | 671 | 716 | 733 | 822 | 869 | 948 | 1,105 | 1,243 | 1,210 | 1,227 | 6,026 | 5,999 |
| Total Assets | 929 | 1,012 | 1,090 | 1,193 | 1,304 | 1,358 | 1,624 | 2,000 | 2,361 | 2,383 | 2,346 | 9,672 | 9,754 |
Below is a detailed analysis of the balance sheet data for Sudarshan Chemical Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,504.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,424.00 Cr. (Mar 2025) to 3,504.00 Cr., marking an increase of 80.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,528.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 2,378.00 Cr. (Mar 2025) to 2,528.00 Cr., marking an increase of 150.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,706.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,854.00 Cr. (Mar 2025) to 3,706.00 Cr., marking a decrease of 148.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 9,754.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,672.00 Cr. (Mar 2025) to 9,754.00 Cr., marking an increase of 82.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,958.00 Cr. (Mar 2025) to 3,057.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2025) to 159.00 Cr., marking an increase of 19.00 Cr..
- For Investments, as of Sep 2025, the value is 539.00 Cr.. The value appears to be declining and may need further review. It has decreased from 548.00 Cr. (Mar 2025) to 539.00 Cr., marking a decrease of 9.00 Cr..
- For Other Assets, as of Sep 2025, the value is 5,999.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,026.00 Cr. (Mar 2025) to 5,999.00 Cr., marking a decrease of 27.00 Cr..
- For Total Assets, as of Sep 2025, the value is 9,754.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,672.00 Cr. (Mar 2025) to 9,754.00 Cr., marking an increase of 82.00 Cr..
Notably, the Reserves (3,504.00 Cr.) exceed the Borrowings (2,528.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -307.00 | -302.00 | -260.00 | -244.00 | -240.00 | -160.00 | -253.00 | -328.00 | -545.00 | -616.00 | -149.00 | 381.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85 | 96 | 92 | 98 | 92 | 79 | 78 | 95 | 83 | 77 | 84 | 134 |
| Inventory Days | 144 | 125 | 113 | 134 | 131 | 119 | 154 | 142 | 163 | 132 | 113 | 507 |
| Days Payable | 63 | 94 | 96 | 139 | 126 | 94 | 139 | 152 | 150 | 136 | 132 | 288 |
| Cash Conversion Cycle | 166 | 127 | 109 | 93 | 96 | 105 | 92 | 85 | 96 | 73 | 65 | 353 |
| Working Capital Days | 41 | 26 | 40 | 14 | 43 | 51 | 24 | 29 | 18 | 23 | 40 | 154 |
| ROCE % | 14% | 16% | 19% | 22% | 18% | 17% | 18% | 17% | 13% | 6% | 11% | 6% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 5,789,852 | 1.45 | 548.7 | N/A | N/A | N/A |
| Tata Small Cap Fund | 4,757,212 | 3.98 | 450.84 | 4,691,125 | 2026-01-26 00:45:39 | 1.41% |
| Axis Small Cap Fund | 1,945,414 | 0.69 | 184.37 | 2,440,688 | 2025-12-08 01:00:56 | -20.29% |
| Franklin India Opportunities Fund | 1,431,787 | 1.62 | 135.69 | N/A | N/A | N/A |
| Nippon India Small Cap Fund | 1,183,578 | 0.16 | 112.17 | 1,083,578 | 2026-01-26 00:45:39 | 9.23% |
| Tata Large & Mid Cap Fund | 1,080,011 | 1.18 | 102.35 | 973,769 | 2025-12-15 00:29:34 | 10.91% |
| DSP Small Cap Fund | 640,000 | 0.36 | 60.65 | N/A | N/A | N/A |
| Franklin India Multi Cap Fund | 592,084 | 1.11 | 56.11 | N/A | N/A | N/A |
| DSP Multicap Fund | 231,765 | 0.82 | 21.96 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 52,253 | 0.03 | 4.95 | 25,000 | 2026-01-26 00:45:39 | 109.01% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 7.90 | 51.60 | 6.50 | 18.80 | 20.40 |
| Diluted EPS (Rs.) | 7.90 | 51.60 | 6.50 | 18.70 | 20.40 |
| Cash EPS (Rs.) | 28.45 | 72.03 | 22.97 | 31.67 | 32.88 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 437.80 | 165.99 | 119.64 | 120.36 | 107.41 |
| Revenue From Operations / Share (Rs.) | 425.78 | 366.74 | 332.50 | 317.92 | 269.28 |
| PBDIT / Share (Rs.) | 52.74 | 48.18 | 31.12 | 40.42 | 42.58 |
| PBIT / Share (Rs.) | 31.59 | 27.78 | 14.62 | 27.53 | 30.08 |
| PBT / Share (Rs.) | 12.26 | 67.97 | 8.63 | 24.72 | 27.50 |
| Net Profit / Share (Rs.) | 7.29 | 51.64 | 6.47 | 18.77 | 20.38 |
| NP After MI And SOA / Share (Rs.) | 7.10 | 51.64 | 6.47 | 18.77 | 20.38 |
| PBDIT Margin (%) | 12.38 | 13.13 | 9.35 | 12.71 | 15.81 |
| PBIT Margin (%) | 7.41 | 7.57 | 4.39 | 8.65 | 11.17 |
| PBT Margin (%) | 2.87 | 18.53 | 2.59 | 7.77 | 10.21 |
| Net Profit Margin (%) | 1.71 | 14.07 | 1.94 | 5.90 | 7.56 |
| NP After MI And SOA Margin (%) | 1.66 | 14.07 | 1.94 | 5.90 | 7.56 |
| Return on Networth / Equity (%) | 1.62 | 31.10 | 5.40 | 15.59 | 18.97 |
| Return on Capital Employeed (%) | 3.64 | 12.88 | 7.23 | 14.59 | 18.20 |
| Return On Assets (%) | 0.57 | 15.17 | 1.87 | 5.48 | 7.04 |
| Long Term Debt / Equity (X) | 0.47 | 0.16 | 0.54 | 0.44 | 0.41 |
| Total Debt / Equity (X) | 0.60 | 0.38 | 0.98 | 0.98 | 0.65 |
| Asset Turnover Ratio (%) | 0.55 | 1.07 | 0.87 | 0.90 | 0.96 |
| Current Ratio (X) | 2.12 | 1.38 | 1.17 | 1.13 | 1.20 |
| Quick Ratio (X) | 1.27 | 0.87 | 0.67 | 0.60 | 0.72 |
| Inventory Turnover Ratio (X) | 2.31 | 5.45 | 2.48 | 2.82 | 2.64 |
| Dividend Payout Ratio (NP) (%) | 12.41 | 9.87 | 77.31 | 31.95 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.11 | 7.08 | 21.77 | 18.94 | 0.00 |
| Earning Retention Ratio (%) | 87.59 | 90.13 | 22.69 | 68.05 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.89 | 92.92 | 78.23 | 81.06 | 0.00 |
| Interest Coverage Ratio (X) | 8.58 | 9.04 | 5.19 | 14.41 | 16.49 |
| Interest Coverage Ratio (Post Tax) (X) | 4.33 | 2.15 | 2.08 | 7.69 | 8.90 |
| Enterprise Value (Cr.) | 8962.37 | 4605.33 | 3488.90 | 4384.53 | 4055.41 |
| EV / Net Operating Revenue (X) | 2.68 | 1.81 | 1.52 | 1.99 | 2.18 |
| EV / EBITDA (X) | 21.63 | 13.81 | 16.19 | 15.67 | 13.76 |
| MarketCap / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| Retention Ratios (%) | 87.58 | 90.12 | 22.68 | 68.04 | 0.00 |
| Price / BV (X) | 2.26 | 3.67 | 3.26 | 4.32 | 4.83 |
| Price / Net Operating Revenue (X) | 2.33 | 1.66 | 1.17 | 1.64 | 1.93 |
| EarningsYield | 0.01 | 0.08 | 0.01 | 0.03 | 0.03 |
After reviewing the key financial ratios for Sudarshan Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.90. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 7.90, marking a decrease of 43.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.90. This value is within the healthy range. It has decreased from 51.60 (Mar 24) to 7.90, marking a decrease of 43.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 28.45. This value is within the healthy range. It has decreased from 72.03 (Mar 24) to 28.45, marking a decrease of 43.58.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 437.80. It has increased from 165.99 (Mar 24) to 437.80, marking an increase of 271.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 425.78. It has increased from 366.74 (Mar 24) to 425.78, marking an increase of 59.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 52.74. This value is within the healthy range. It has increased from 48.18 (Mar 24) to 52.74, marking an increase of 4.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 31.59. This value is within the healthy range. It has increased from 27.78 (Mar 24) to 31.59, marking an increase of 3.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has decreased from 67.97 (Mar 24) to 12.26, marking a decrease of 55.71.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.29. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.29, marking a decrease of 44.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.10. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 7.10, marking a decrease of 44.54.
- For PBDIT Margin (%), as of Mar 25, the value is 12.38. This value is within the healthy range. It has decreased from 13.13 (Mar 24) to 12.38, marking a decrease of 0.75.
- For PBIT Margin (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 10. It has decreased from 7.57 (Mar 24) to 7.41, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 2.87. This value is below the healthy minimum of 10. It has decreased from 18.53 (Mar 24) to 2.87, marking a decrease of 15.66.
- For Net Profit Margin (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 5. It has decreased from 14.07 (Mar 24) to 1.71, marking a decrease of 12.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 8. It has decreased from 14.07 (Mar 24) to 1.66, marking a decrease of 12.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 15. It has decreased from 31.10 (Mar 24) to 1.62, marking a decrease of 29.48.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.64. This value is below the healthy minimum of 10. It has decreased from 12.88 (Mar 24) to 3.64, marking a decrease of 9.24.
- For Return On Assets (%), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 5. It has decreased from 15.17 (Mar 24) to 0.57, marking a decrease of 14.60.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 0.47, marking an increase of 0.31.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has increased from 0.38 (Mar 24) to 0.60, marking an increase of 0.22.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 1.07 (Mar 24) to 0.55, marking a decrease of 0.52.
- For Current Ratio (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.38 (Mar 24) to 2.12, marking an increase of 0.74.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 0.87 (Mar 24) to 1.27, marking an increase of 0.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 4. It has decreased from 5.45 (Mar 24) to 2.31, marking a decrease of 3.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 12.41. This value is below the healthy minimum of 20. It has increased from 9.87 (Mar 24) to 12.41, marking an increase of 2.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.11. This value is below the healthy minimum of 20. It has decreased from 7.08 (Mar 24) to 3.11, marking a decrease of 3.97.
- For Earning Retention Ratio (%), as of Mar 25, the value is 87.59. This value exceeds the healthy maximum of 70. It has decreased from 90.13 (Mar 24) to 87.59, marking a decrease of 2.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.89. This value exceeds the healthy maximum of 70. It has increased from 92.92 (Mar 24) to 96.89, marking an increase of 3.97.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.58. This value is within the healthy range. It has decreased from 9.04 (Mar 24) to 8.58, marking a decrease of 0.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has increased from 2.15 (Mar 24) to 4.33, marking an increase of 2.18.
- For Enterprise Value (Cr.), as of Mar 25, the value is 8,962.37. It has increased from 4,605.33 (Mar 24) to 8,962.37, marking an increase of 4,357.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has increased from 1.81 (Mar 24) to 2.68, marking an increase of 0.87.
- For EV / EBITDA (X), as of Mar 25, the value is 21.63. This value exceeds the healthy maximum of 15. It has increased from 13.81 (Mar 24) to 21.63, marking an increase of 7.82.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For Retention Ratios (%), as of Mar 25, the value is 87.58. This value exceeds the healthy maximum of 70. It has decreased from 90.12 (Mar 24) to 87.58, marking a decrease of 2.54.
- For Price / BV (X), as of Mar 25, the value is 2.26. This value is within the healthy range. It has decreased from 3.67 (Mar 24) to 2.26, marking a decrease of 1.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has increased from 1.66 (Mar 24) to 2.33, marking an increase of 0.67.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 24) to 0.01, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sudarshan Chemical Industries Ltd:
- Net Profit Margin: 1.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.64% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.62% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 67.7 (Industry average Stock P/E: 89.71)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | 7th Floor, Eleven West Panchshil, Pune Maharashtra 411045 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rajesh B Rathi | Chairman & Managing Director |
| Mr. Ashish Vij | Whole Time Director |
| Mr. Naresh T Raisinghani | Ind. Non-Executive Director |
| Mrs. Shubhalakshmi A Panse | Ind. Non-Executive Director |
| Mrs. Anu A Wakhlu | Ind. Non-Executive Director |
| Mrs. Sudha P Navandar | Ind. Non-Executive Director |
| Ms. Bhumika Batra | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Sudarshan Chemical Industries Ltd?
Sudarshan Chemical Industries Ltd's intrinsic value (as of 27 January 2026) is ₹615.53 which is 30.37% lower the current market price of ₹884.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,948 Cr. market cap, FY2025-2026 high/low of ₹1,604/796, reserves of ₹3,504 Cr, and liabilities of ₹9,754 Cr.
What is the Market Cap of Sudarshan Chemical Industries Ltd?
The Market Cap of Sudarshan Chemical Industries Ltd is 6,948 Cr..
What is the current Stock Price of Sudarshan Chemical Industries Ltd as on 27 January 2026?
The current stock price of Sudarshan Chemical Industries Ltd as on 27 January 2026 is ₹884.
What is the High / Low of Sudarshan Chemical Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sudarshan Chemical Industries Ltd stocks is ₹1,604/796.
What is the Stock P/E of Sudarshan Chemical Industries Ltd?
The Stock P/E of Sudarshan Chemical Industries Ltd is 67.7.
What is the Book Value of Sudarshan Chemical Industries Ltd?
The Book Value of Sudarshan Chemical Industries Ltd is 448.
What is the Dividend Yield of Sudarshan Chemical Industries Ltd?
The Dividend Yield of Sudarshan Chemical Industries Ltd is 0.51 %.
What is the ROCE of Sudarshan Chemical Industries Ltd?
The ROCE of Sudarshan Chemical Industries Ltd is 6.03 %.
What is the ROE of Sudarshan Chemical Industries Ltd?
The ROE of Sudarshan Chemical Industries Ltd is 3.07 %.
What is the Face Value of Sudarshan Chemical Industries Ltd?
The Face Value of Sudarshan Chemical Industries Ltd is 2.00.